Revive Therapeutics (RVVTF) Regulatory Update Archive.
April 12th, 2022 update. Discusses potentially halting the Study early due to positive efficacy based on other clinical outcomes evaluated such as the rate...
Deficiency of Glutathione as the Most Likely Cause of Serious Manifestations and Death in...
American Chemical Society
May 2020.
Higher rates of serious illness and death from coronavirus SARS-CoV-2 (COVID-19) infection among older people and those who have comorbidities...
Revive Therapeutics Announces Entry Into Phase III FDA Trial Using Glutathione Boosting Bucillamine.
Revive Therapeutics Announces U.S. FDA Recommendation to Proceed Directly Into A Phase 3 Confirmatory Clinical Trial
TORONTO, April 23, 2020 (GLOBE NEWSWIRE) --Revive Therapeutics Ltd.Ltd....
Latest article
CFO Primer. Tokenize Your Stock?
Had a conversation over Mimosa's Sunday morning with one of our AI Analyst on the tokenization of publicly traded companies, and some interesting information...
Inside the Wild Ride of ATAI (ATAI) $7.22. We’re Up And Out, With a...
Our 6th Billion Dollar Gainer. We're Saying Auf Wiedersehen!
Eli Lilly (LLY) has agreed to pay $6.75 a share in cash upfront ($2.8 billion) –...
AI Meets Mining. MineSignal.AI – Public Inputs – Proprietary Outputs.
MineSignal AI is a technology company that embeds engineers into your business to create and deploy custom AI workflows. It connects directly to your...
